OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Learning cell identity in immunology, neuroscience, and cancer	269
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	88
Vascular galectins in tumor angiogenesis and cancer immunity	82
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	72
Regulatory T lymphocytes as a therapy for ischemic stroke	68
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy	60
Role of polyamines in intestinal mucosal barrier function	57
The microbiome’s hidden influence: preclinical insights into inflammatory responses in necrotizing enterocolitis	55
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	54
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	51
Correction to: Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	51
Regenerating the uterus: translational advances in endometrial bioengineering and immunotherapeutics	49
Thromboinflammatory challenges in stroke pathophysiology	49
The role of vaccines in the COVID-19 pandemic: what have we learned?	49
Immune checkpoint for pregnancy	49
Publisher Correction: Epithelial recognition and elimination against aberrant cells	49
Towards multiomic analysis of oral mucosal pathologies	48
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective	47
The role of microglia in early neurodevelopment and the effects of maternal immune activation	45
Immunization of preterm infants: current evidence and future strategies to individualized approaches	44
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation	43
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries	42
Single-cell RNA-seq methods to interrogate virus-host interactions	40
Tolerance and autoimmunity in the liver	37
CAF-immune cell crosstalk and its impact in immunotherapy	36

Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	36
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	35
Correction to: MAIT cells in liver inflammation and fibrosis	35
The aging immune system in Alzheimer’s and Parkinson’s diseases	33
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	33
Revisiting transplant immunology through the lens of single-cell technologies	33
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	29
Beyond defence: Immune architects of ovarian health and disease	28
CAR T-cell behavior and function revealed by real-time imaging	28
Local anesthetics and immunotherapy: a novel combination to fight cancer	27
Arginine metabolism in myeloid cells in health and disease	26
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment	26
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women	26
Immune compartments at the brain’s borders in health and neurovascular diseases	25
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers	23
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition	23
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy	23
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease	22
Harnessing the liver to induce antigen-specific immune tolerance	22
How genetic risk contributes to autoimmune liver disease	20
Role of alarmins in poststroke inflammation and neuronal repair	20
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system	20
Gut microbiota-derived metabolites tune host homeostasis fate	20
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	19
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	19
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	18
Proteomics to study cancer immunity and improve treatment	18
Maternal and placental galectins: key players in the feto-maternal symbiotic tango	17
Tumor microenvironment antigens	17
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	16
The role of circulating cell-free DNA as an inflammatory mediator after stroke	15
Intracellular galectin interactions in health and disease	15
IgE and non-IgE-mediated pathways in anaphylaxis	14
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	14
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	14
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells	14
Physiological and immunological barriers in the lung	14
Cell therapies for viral diseases: a new frontier	14
Heterogeneity of tissue-resident immunity across organs and in health and disease	13
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment	13